Item 3.02 Unregistered Sales of Equity Securities.

On January 28, 2013, Rockwell Medical, Inc. (the "Company") and the holders of the remaining unexercised warrants to purchase Company common stock at $7.18 per share in cash issued in the Company's November 2007 private offering (the "Private Offering Warrants") agreed to further extend the expiration date for the Private Offering Warrants from January 28, 2013 to July 31, 2013. The Private Offering Warrants became exercisable on November 28, 2008 and 1,008,336 remain outstanding and unexercised. To the extent the amendments constitute an issuance of securities, the deemed exchange of the original warrants for warrants with the modified terms for no additional consideration and without paying remuneration for soliciting such exchange was exempt under
Section 3(a)(9) of the Securities Act.

The foregoing does not purport to be a complete description of the warrant amendment and is qualified in its entirety by reference to the full text of the warrant amendment, which is attached hereto as Exhibit 4.17 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

Exhibit number Exhibit Description 4.17 Form of Amendment to Common Stock Warrant, dated as of January 28, 2013, amending warrants issued in private offering in November 2007